Alantos Pharmaceuticals, Inc.
Alantos is a drug discovery company developing a new combinatorial approach known as dynamic combinatorial chemistry. This approach was pioneered in the laboratory of Jean-Marie Lehn, Nobel Laureate for Chemistry (1987) and one of Alantos's founders, and in various other academic laboratories around the world. Dynamic combinatorial chemistry uses special types of libraries that can "evolve" via interaction with the biological target to produce preferentially or exclusively only those library components that bind tightly to the target and can further be converted into drug leads and development candidates. Alantos technology thus accelerates and advances the process of small molecule drug discovery via combination of synthesis and screening in a single step and alleviation of synthesis and handling of inactive compounds.
Alantos has its headquarters in Heidelberg, Germany and a research subsidiary in Cambridge, MA.